BTAIQOTCPharmaceutical PreparationsFiscal year ends December 31
BioXcel Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.03−0.00 (-13.49%)
Close on Oct 19, 2026
- Market cap
- $757.50K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
19.7%
6M of 31M shares
Institutional holders
46
10 new, 3 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 4 sales
Net sold $43.17K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Vimal Mehta | 8,830,622 | 23.50% | 13D (active) amendment | Jun 6, 2024 |
| Oaktree Capital Holdings, LLC | 2,724,075 | 5.20% | 13G (passive) | Nov 25, 2024 |
| Israel A. Englander | 1,835,192 | 8.40% | 13G (passive) amendment | Dec 31, 2025 |
| Millennium Group Management LLC | 1,028,053 | 5.20% | 13G (passive) | Sep 29, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BTAIQ | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Millennium Management LLC | 2,114,710 | 6.76% | $2.98M | +177,950 | 0.00% |
| Oaktree Capital Management LP | 1,380,248 | 4.41% | $1.95M | +1,139,060 | 0.03% |
| Vanguard Capital Management LLC | 919,545 | 2.94% | $1.30M | +712,206 | 0.00% |
| Oaktree Fund Advisors, LLC | 245,585 | 0.78% | $346.27K | +202,672 | 0.60% |
| Geode Capital Management, LLC | 242,251 | 0.77% | $341.91K | +12,083 | 0.00% |
| BlackRock, Inc. | 179,433 | 0.57% | $253.00K | +95,151 | 0.00% |
| UBS Group AG | 158,065 | 0.50% | $222.87K | +105,277 | 0.00% |
| Citadel Advisors LLC | 149,220 | 0.48% | $210.40K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 136,937 | 0.44% | $193.08K | +52,016 | 0.00% |
| State Street Corp | 92,118 | 0.29% | $129.89K | – | 0.00% |
| FMR LLC | 90,300 | 0.29% | $127.32K | – | 0.00% |
| &partners | 83,588 | 0.27% | $117.86K | +2,724 | 0.00% |
| Jones Financial Companies Lllp | 63,139 | 0.20% | $82.71K | −68,650 | 0.00% |
| Northern Trust Corp | 56,318 | 0.18% | $79.41K | +20,005 | 0.00% |
| HighTower Advisors, LLC | 41,000 | 0.13% | $57.81K | – | 0.00% |
| Quadrature Capital Ltd | 38,038 | 0.12% | $53.63K | New | 0.00% |
| Headlands Technologies LLC | 25,556 | 0.08% | $36.03K | New | 0.00% |
| StoneX Group Inc. | 20,684 | 0.07% | $29.16K | New | 0.00% |
| Beacon Pointe Advisors, LLC | 18,837 | 0.06% | $26.56K | −40 | 0.00% |
| Susquehanna International Group, Llp | 17,200 | 0.05% | $24.25K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 46 | 6M | 19.7% | 10 / 12 | 8 / 3 | 3M | 2M |
| Q1 2026 | 40 | 5M | 17.4% | 8 / 9 | 7 / 8 | 3M | 0M |
| Q4 2025 | 41 | 4M | 11.3% | 11 / 11 | 8 / 4 | 1M | 0M |
| Q3 2025 | 35 | 2M | 7.5% | 9 / 14 | 3 / 9 | 2M | 0M |
| Q2 2025 | 35 | 1M | 2.0% | 9 / 6 | 8 / 5 | 0M | 0M |
| Q1 2025 | 31 | 0M | 1.2% | 31 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BTAIQ | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 679,570 | 2.17% | $958.19K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 207,339 | 0.66% | $292.35K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 105,892 | 0.34% | $123.89K | 0.00% | May 31, 2026 |
| Select Biotechnology Portfolio | 90,300 | 0.29% | $105.65K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 89,205 | 0.28% | $125.78K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 34,237 | 0.11% | $40.06K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 29,546 | 0.09% | $34.57K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 10,872 | 0.03% | $12.72K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 5,946 | 0.02% | $8.38K | 0.00% | Jun 30, 2026 |
| Total Stock Market Index Trust | 651 | 0.00% | $918 | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -9,455 | -0.03% | -$13.33K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Vimal Mehta | CEO and President, Director | 550,285 | 1.76% | Jun 17, 2026 |
| Richard I. Steinhart | Chief Financial Officer | 26,335 | 0.08% | Jun 17, 2026 |
| Javier Rodriguez | See Remarks | 26,838 | 0.09% | Jun 17, 2026 |
| Frank Yocca | Chief Scientific Officer | 26,210 | 0.08% | Jun 17, 2026 |
| Susan E. Atkins | Director | – | – | Aug 14, 2026 |
| Michal Votruba | Director | – | – | Jan 12, 2026 |
| David J. Mack | Director | 20,317 | 0.06% | Jan 12, 2026 |
| Sandeep Laumas | Director | – | – | Jan 12, 2026 |
| Rajiv Patni | Director | – | – | Jan 12, 2026 |
| Peter Mueller | Director | 299,795 | 0.96% | Jan 12, 2026 |
| Michael Patrick Miller | Director | – | – | Jan 12, 2026 |
| June Bray | Director | – | – | Jan 12, 2026 |
| Matthew T. Wiley | – | 19,011 | 0.06% | Apr 1, 2025 |
| Vincent O'Neill | – | 19,957 | 0.06% | Apr 1, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Vimal Mehta CEO and President, Director | Jun 15, 2026 | Option exercise | +219 | – | – | 69,817 |
| Frank Yocca Chief Scientific Officer | Jun 15, 2026 | Option exercise | +35 | – | – | 26,210 |
| Javier Rodriguez See Remarks | Jun 15, 2026 | Option exercise | +35 | – | – | 26,838 |
| Richard I. Steinhart Chief Financial Officer | Jun 15, 2026 | Option exercise | +35 | – | – | 26,335 |
| Javier Rodriguez See Remarks | May 20, 2026 | Sale(10b5-1 plan) | −6,560 | $1.08 | $7.08K | 26,803 |
| Frank Yocca Chief Scientific Officer | May 20, 2026 | Sale(10b5-1 plan) | −6,845 | $1.09 | $7.46K | 26,175 |
| Vimal Mehta CEO and President, Director | May 20, 2026 | Sale(10b5-1 plan) | −19,419 | $1.09 | $21.17K | 69,598 |
| Richard I. Steinhart Chief Financial Officer | May 20, 2026 | Sale(10b5-1 plan) | −6,845 | $1.09 | $7.46K | 26,300 |
| Javier Rodriguez See Remarks | May 4, 2026 | Option exercise | +17,500 | – | – | 33,363 |
| Frank Yocca Chief Scientific Officer | May 4, 2026 | Option exercise | +17,500 | – | – | 33,020 |
| Vimal Mehta CEO and President, Director | May 4, 2026 | Option exercise | +49,758 | – | – | 89,017 |
| Richard I. Steinhart Chief Financial Officer | May 4, 2026 | Option exercise | +17,500 | – | – | 33,145 |
| Vimal Mehta CEO and President, Director | May 1, 2026 | Option exercise | +18,000 | – | – | 39,259 |
| Richard I. Steinhart Chief Financial Officer | May 1, 2026 | Option exercise | +9,000 | – | – | 15,645 |
| Frank Yocca Chief Scientific Officer | May 1, 2026 | Option exercise | +9,000 | – | – | 15,520 |
| Javier Rodriguez See Remarks | May 1, 2026 | Option exercise | +9,000 | – | – | 15,863 |
| Vimal Mehta CEO and President, Director | Mar 15, 2026 | Option exercise | +219 | – | – | 21,259 |
| Javier Rodriguez See Remarks | Mar 15, 2026 | Option exercise | +35 | – | – | 6,863 |
| Richard I. Steinhart Chief Financial Officer | Mar 15, 2026 | Option exercise | +35 | – | – | 6,645 |
| Frank Yocca Chief Scientific Officer | Mar 15, 2026 | Option exercise | +35 | – | – | 6,520 |
| Vimal Mehta CEO and President, Director | Mar 14, 2026 | Option exercise | +164 | – | – | 21,040 |
| Javier Rodriguez See Remarks | Mar 14, 2026 | Option exercise | +33 | – | – | 6,828 |
| Richard I. Steinhart Chief Financial Officer | Mar 14, 2026 | Option exercise | +33 | – | – | 6,610 |
| Frank Yocca Chief Scientific Officer | Mar 14, 2026 | Option exercise | +33 | – | – | 6,485 |
| Frank Yocca Chief Scientific Officer | Dec 15, 2025 | Option exercise | +35 | – | – | 6,452 |
| Vimal Mehta CEO and President, Director | Dec 15, 2025 | Option exercise | +219 | – | – | 20,876 |
| Javier Rodriguez See Remarks | Dec 15, 2025 | Option exercise | +35 | – | – | 6,795 |
| Richard I. Steinhart Chief Financial Officer | Dec 15, 2025 | Option exercise | +35 | – | – | 6,577 |
| Frank Yocca Chief Scientific Officer | Dec 14, 2025 | Option exercise | +33 | – | – | 6,417 |
| Vimal Mehta CEO and President, Director | Dec 14, 2025 | Option exercise | +164 | – | – | 20,657 |
| Javier Rodriguez See Remarks | Dec 14, 2025 | Option exercise | +33 | – | – | 6,760 |
| Richard I. Steinhart Chief Financial Officer | Dec 14, 2025 | Option exercise | +33 | – | – | 6,542 |
| David J. Mack Director | Oct 31, 2025 | Option exercise | +1,694 | – | – | 20,317 |
| David J. Mack Director | Sep 30, 2025 | Option exercise | +1,694 | – | – | 18,623 |
| Richard I. Steinhart Chief Financial Officer | Sep 15, 2025 | Option exercise | +35 | – | – | 6,509 |
| Frank Yocca Chief Scientific Officer | Sep 15, 2025 | Option exercise | +35 | – | – | 6,384 |
| Javier Rodriguez See Remarks | Sep 15, 2025 | Option exercise | +35 | – | – | 6,727 |
| Vimal Mehta CEO and President, Director | Sep 15, 2025 | Option exercise | +219 | – | – | 20,493 |
| Richard I. Steinhart Chief Financial Officer | Sep 14, 2025 | Option exercise | +33 | – | – | 6,474 |
| Frank Yocca Chief Scientific Officer | Sep 14, 2025 | Option exercise | +33 | – | – | 6,349 |
| Javier Rodriguez See Remarks | Sep 14, 2025 | Option exercise | +33 | – | – | 6,692 |
| Vimal Mehta CEO and President, Director | Sep 14, 2025 | Option exercise | +163 | – | – | 20,274 |
| David J. Mack Director | Aug 31, 2025 | Option exercise | +1,693 | – | – | 16,930 |
| David J. Mack Director | Jul 31, 2025 | Option exercise | +1,693 | – | – | 15,237 |
| Javier Rodriguez See Remarks | Jul 22, 2025 | Award | +4,375 | – | – | 6,034 |
| Javier Rodriguez See Remarks | Jul 22, 2025 | Option exercise | +625 | – | – | 6,659 |
| Richard I. Steinhart Chief Financial Officer | Jul 22, 2025 | Option exercise | +625 | – | – | 6,441 |
| Richard I. Steinhart Chief Financial Officer | Jul 22, 2025 | Award | +4,375 | – | – | 5,816 |
| Frank Yocca Chief Scientific Officer | Jul 22, 2025 | Award | +4,375 | – | – | 6,316 |
| Vimal Mehta CEO and President, Director | Jul 22, 2025 | Award | +15,625 | – | – | 20,111 |
| David J. Mack Director | Jun 30, 2025 | Option exercise | +1,693 | – | – | 13,544 |
| Vimal Mehta CEO and President, Director | Jun 15, 2025 | Option exercise | +219 | – | – | 4,486 |
| Richard I. Steinhart Chief Financial Officer | Jun 15, 2025 | Option exercise | +35 | – | – | 1,441 |
| Javier Rodriguez See Remarks | Jun 15, 2025 | Option exercise | +35 | – | – | 1,659 |
| Frank Yocca Chief Scientific Officer | Jun 15, 2025 | Option exercise | +35 | – | – | 1,941 |
| Vimal Mehta CEO and President, Director | Jun 14, 2025 | Option exercise | +163 | – | – | 4,267 |
| Richard I. Steinhart Chief Financial Officer | Jun 14, 2025 | Option exercise | +33 | – | – | 1,406 |
| Javier Rodriguez See Remarks | Jun 14, 2025 | Option exercise | +33 | – | – | 1,624 |
| Frank Yocca Chief Scientific Officer | Jun 14, 2025 | Option exercise | +33 | – | – | 1,906 |
| David J. Mack Director | May 31, 2025 | Option exercise | +1,693 | – | – | 11,851 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Vimal Mehta Officer | May 20, 2026 | 19,419 | $21.11K | May 20, 2026 | Vesting of restricted stock unit awards |
| Javier Rodriguez Officer | May 20, 2026 | 6,560 | $7.11K | May 20, 2026 | Vesting of restricted stock unit awards |
| Frank Yocca Officer | May 20, 2026 | 6,845 | $7.43K | May 20, 2026 | Vesting of restricted stock unit awards |
| Richard I. Steinhart Officer | May 20, 2026 | 6,845 | $7.43K | May 20, 2026 | Vesting of restricted stock unit awards |
| Javier Rodriguez Officer | Dec 16, 2024 | 430 | $153 | Dec 16, 2024 | Restricted Stock Units |
| Vincent O'Neill Officer | Dec 16, 2024 | 165 | $58 | Dec 16, 2024 | Restricted Stock Units |
| Frank Yocca Officer | Dec 16, 2024 | 430 | $152 | Dec 16, 2024 | Restricted Stock Units |
| Richard I. Steinhart Officer | Dec 16, 2024 | 438 | $154 | Dec 16, 2024 | Restricted Stock Units |
| Richard I. Steinhart Officer | Dec 16, 2024 | 430 | $154 | Dec 16, 2024 | Restricted Stock Units |
| Vimal Mehta Officer | Dec 16, 2024 | 2,298 | $793 | Dec 16, 2024 | Restricted Stock Units |
| Javier Rodriguez Officer | Oct 3, 2024 | 6,863 | $3.78K | Oct 3, 2024 | Performance Stock Units |
| Vincent O'Neill Officer | Oct 3, 2024 | 5,556 | $3.06K | Oct 3, 2024 | Performance Stock Units |
| Frank Yocca Officer | Oct 3, 2024 | 7,175 | $3.95K | Oct 3, 2024 | Performance Stock Units |
| Richard I. Steinhart Officer | Oct 3, 2024 | 7,175 | $3.95K | Oct 3, 2024 | Performance stock unit |
| Matthew T. Wiley Officer | Oct 3, 2024 | 6,272 | $3.45K | Oct 3, 2024 | Performance Stock Units |